The aim of this study was to explore the impact of ankylosing spondylitis (AS) and the disease-related variables, psychological status and the quality of life on the female patients' sexual function measured according to the Female Sexual Function Index (FSFI). Thirty-seven sexually active female AS patients and 33 healthy controls were enroled in this study. Their demographic data were evaluated and the generalised pain in patients with AS was assessed according to the visual analogue scale (0-100 mm). Laboratory tests were conducted in order to measure the C-reactive protein (CRP) and erythrocyte sedimentation rates (ESR) of the patients. In comparison to the healthy control group, patients with AS had significantly lower scores in each of the five domains of the FSFI except for the pain domain (Po0.05). The disease activity, functional status, quality of life, radiological score and CRP levels were negatively correlated with the FSFI (Po0.05). No significant correlation was observed with the disease duration, smoking status, depression, anxiety, pain and ESR when the total scores and the scores from the domains of the FSFI were compared. The sexual function is impaired in female patients with AS. This impairment in the sexual function is especially related to the functional status and disease activity among the clinical and laboratory parameters.
INTRODUCTION
Ankylosing spondylitis (AS) is a systemic and chronic inflammatory disease of the axial skeleton, which presents itself with progressive stiffness of spine and back pain. Inflammation and pain in vertebral column and joints result in a decrease in the physical activity and lead to fatigue, sleep disturbances, depression, anxiety and stress. 1, 2 Beyond the sexual act itself, sexuality is a complex aspect of human life and the sexual expression has been cited as a crucial part of an individual's self identity; therefore it is important in all stages of health and illness. 3 Although the effect of inflammatory arthritis on sexuality has already been described, 4, 5 sexual activity is still a frequently neglected domain in patients with rheumatic disease. 6 Impaired function, pain, fatigue and stiffness as well as the psychological responses to chronic disease such as depression may have a negative effect on the sexual activity of the patients. 7 Sexual function is an important component of the quality of life. Due to the axial and peripheral joint involvement and the noticeable inflammation, AS can have a severe impact on a patient's health status, functionality and quality of life. 1, 6, 7 There are few studies concerning the sexual problems in patients with AS, and most of these studies have been conducted on male patients. Previous studies have revealed that sexual life is negatively impacted in male patients with AS. [7] [8] [9] It has been shown that male patients with AS have significantly lower sexual function scores compared with the healthy controls. 9 Our consideration was focussed on the extent that the laboratory parameters, disease activity, functional status, radiological score, depression, anxiety and the change in the quality of life that are inherent to the nature of AS affect the quality of sexual life. The aim of this study was to explore the impact of AS and the disease-related variables on female sexual activity.
PATIENTS AND METHODS
The present study had a cross-sectional design, which was approved by the local ethics committee. All of the recruited subjects signed an informed consent form before participating in the study. A total of 37 sexually active female patients with AS were enroled in the study. The diagnosis of AS was based on the modified New York criteria. Patients were chosen from among the individuals who applied to two centres of Physical Medicine and Rehabilitation at university hospitals in Turkey between November 2011 and January 2012. The control group consisting of 33 healthy volunteers were randomly chosen from amongt the employees (agematched nurses were invited) of our hospital. In both groups, the participants were 22-50 years old and married, premenopausal woman who had active sex lives during the last 4 weeks before joining the study.
The following exclusion criteria were specified: subjects with pulmonary, hepatic, haematological or renal diseases; endocrine disorders such as diabetes mellitus and thyroid function disorder, or systemic disorders such as hormonal, musculogenic, neurogenic and cardiovascular diseases that may affect the sexual function; those using prostheses, with malignancies or a history of psychological disorders, and patients under treatment with b-blockers or antidepressants.
used to evaluate the radiological damage.
14 The erythrocyte sedimentation rate (ESR) was measured through the Westergren method (mmh À 1 ) and the serum C-reactive protein (CRP) level was measured by nephelometry (mgdl À 1 ). Disease-related quality of life was measured with the Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL). 15 This questionnaire consists of 18 items with dichotomous responses (yes or no). Total scores range from 0 to 18, with a higher score indicating poor quality of life. The reliability and validity of the Turkish version of this questionnaire has been verified by Duruoz et al. 16 Measurements of the psychological variables The Hospital Anxiety and Depression Scale (HADS) was completed by the patients with AS. This scale was developed by Zigmond and Snaith 17 , and the Turkish version of this scale has been verified in terms of its validity and reliability by Aydemir et al. 18 HADS is a Likert-type self evaluation scale which consists of 14 items; seven to investigate the depression symptoms (HADS-D) and the other seven to investigate anxiety symptoms (HADS-A). Higher scores indicate poor psychological status.
Measures of the sexual function
Female sexual function was evaluated using the validated Turkish version of the Female Sexual Function Index (FSFI) described by Rosen et al. 19, 20 This index includes the domains of sexual desire (two items), arousal (four items), lubrication (four items), orgasm (three items), satisfaction (three items) and pain (three items) during sexual intercourse. Every domain is scored between 0 and 5 or 1 and 5. The total score is between 2 and 36. Higher scores indicate a better function.
Statistical analysis
Analyses were carried out using the Statistical Package for Social Sciences software version 16.0 for Windows (SPSS Inc., Chicago, IL, USA). The Kolmogorov-Smirnov test was used to confirm that data were normally distributed. The comparison of data between the two groups was carried out through the independent-samples t-test. Correlations between the sexual dysfunction, depression-anxiety status and AS indexes were investigated with the help of Spearman's correlation method. Statistical significance was based on a value of Po0.05 with a 95% confidence interval.
RESULTS
The mean ages of the patient and the control groups were 34.11 ± 7.0 and 33.5 ± 6.2, respectively. The age difference was not statistically significant (P ¼ 0.185). The clinical and demographic characteristics of the patients and healthy controls are listed in Table 1 . None of the female patients with AS had hip or knee involvement. Four patients (8.1%) in the patient group and three individuals (9.1%) among the healthy controls were smokers. The other participants were non-smokers for at least the last year. The patients with AS had significantly lower scores in each of the five domains of the FSFI compared with the healthy control group (Po0.05), with the exception of the pain domain ( Table 2 ).
The relationship between the FSFI scores and the clinical parameters According to the Spearman analysis, there was a significant negative correlation between the BASFI scores and the scores obtained from all the domains of the FSFI (Po0.05). The BASDAI was negatively correlated with the scores from the sexual desire, lubrication and pain domains and the FSFI total score (Po0.05). The BASRI and duration of morning stiffness were also negatively correlated with the sexual desire score (Po0.05). No significant correlation was observed with the disease duration, smoking status, pain (with visual analogue scale) and BASMI levels when the total scores and the domain scores of the FSFI were compared ( Table 3) .
The relationship between the FSFI scores, psychological status and ASQoL No significant correlation was observed between the HADS-A and HADS-D levels and the FSFI. The ASQoL was negatively correlated with all the domains of the FSFI except for the pain domain (Po0.05) ( Table 3) .
The relationship between the FSFI scores and the laboratory parameters CRP was negatively correlated with the satisfaction domain score and the FSFI total score (Po0.05). No significant correlation was observed between the ESR values and the FSFI (P40.05) ( Table 3) .
Among all the patients, 21.9% were treated only with NSAIDs, 56.8% received NSAIDs and sulphasalazine, and 21.3% were on anti-tumor necrosis factor and NSAIDs simultaneously. No significant relationship was observed between the treatment modality and the FSFI scores (P40.05).
DISCUSSION
Sexual activity is an important factor in women's quality of life. 21 A healthy locomotor system and mood are necessary for normal sexual functioning. All domains of sexual activity may be affected by rheumatic diseases. 7 In our study, all of the FSFI domain scores except for the pain score were significantly lower in patients with AS compared with the healthy controls.
Only a limited number of studies to date have investigated the sexual function in patients with AS, and a decrease in sexual function was observed in most of these studies. 8, 9, 22 The number of the studies focussing on the sexual function of female patients with AS is even lower. Healey et al. 6 have investigated the influence of the gender difference on the sexual functions of AS patients, and found that the sexual function in female patients with AS were as much affected as in male patients. In a recent study, the sexual function was investigated in female patients with AS and showed that there were no differences between AS patients with healthy individuals in contrast to our study. In that study by Demir et al., 23 the mean age of the patient and control groups was higher than our patients. Advancing age may have an impact on sexual activity. Also, especially in female patients, AS takes a milder course as the age advances, and this may have concealed the changes in the sexual activity. On the other hand; in the study by Demir et al., 23 no significant difference was observed in terms of the lubrication, orgasm, satisfaction and pain subscores and the FSFI total score. The number of our patients was higher than study by Demir et al. 23 Thus, our results may more accurately explain the disturbance in the sexual activity in female patients with AS.
In our study, the pain domain scores on the FSFI were comparably high among the healthy controls and the patients. In previous studies, painful intercourse was reported as an important problem among healthy Turkish women, with 42.9% of healthy women experiencing pain during intercourse. 20 As painful intercourse is a commonly observed problem among the women in our country, our study may have found higher pain scores both in the patient and control groups. In the same study, smoking, menopause and marital status have been found as important factors affecting female sexuality. In our study, all of the individuals in the patient and control groups were married and premenopausal, and only a small number were smokers. This may be the reason why no relationship has been observed between smoking and sexual dysfunction in the correlation analysis.
The major finding of the our study is that the BASFI, BASDAI and ASQoL scores are correlated with the female sexual function in patients with AS. BASFI is negatively correlated with the individual scores from each domain and total score of the FSFI. Previous studies have revealed that higher BASFI and BASDAI scores are associated with sexual dysfunction in male patients with AS. 6, 7 In a study where the female and male patients with AS were evaluated together, higher BASDAI and BASFI scores were found to be associated with sexual dysfunction. 6 A recent study showed that functional status of the female patients with AS was correlated with sexual functions, also it was reported that pain and disease activity had negative impact on sexual functions. However, there was no correlation between spinal mobility, laboratory parameters and sexual functions. 23 AS is a disease that limits the mobility of the axial skeletonespecially in the lower back-which in turn leads to a decrease in the physical activity during sexual intercourse. In our study no correlation was observed between the BASMI and female sexual function. This may be explained with the milder course of AS in women and the better prognosis of the female patients with AS.
In our study, the BASDAI score was found to be negatively correlated with the sexual desire, lubrication and pain domains score, and the total score of the FSFI. Also we found that, the duration of morning stiffness was not correlated with any of the FSFI domains. Pirildar et al. 9 showed that only the morning stiffness was related to the male sexual function, although another study 8 failed to reveal any relationship between the duration of the morning stiffness and the sexual function. However, in a study conducted in female patients with RA, morning stiffness over a long period has been demonstrated to be associated with sexual dissatisfaction. 24 It is thought that the differences observed in the results are related to the different evaluation parameters and the different questionnaires used to determine the sexual function, as well as the fact that the studies were conducted in different societies.
BASRI score was found to be negatively correlated with sexual desire and the total FSFI score in this study. Previous studies did not evaluate the relationship between the radiological score and sexual function. On the other hand; previous studies have shown that the quality of life and the functional indices are correlated with the BASRI scores. [25] [26] [27] [28] Yacoub et al. 28 revealed a correlation between the domain scores of the SF-36 and the BASRI. Many studies have demonstrated the relationship between impaired spinal mobility and the radiological scores in AS patients. 29, 30 In our study, the impairment in the quality of life and the deterioration in the physical functions may have affected the sexual function in those patients with higher BASRI scores. Also in our study, The ASQoL was negatively correlated with all the domains of the FSFI except for the pain domain. In line with our study, Cakar et al. 7 also reported that subscale scores of SF-36 were worse in the male patients whose sexual function was affected. In another study, 22 male sexual function was observed to be negatively correlated with the social function item of the SF-36.
In this study, the satisfaction domain score and the total score of FSFI were negatively correlated with the CRP levels. But none of the FSFI scores were related to the ESR levels. Dougados et al. 31 suggested that increases in the CRP levels in AS patients with axial involvement correlated with the clinical severity of the disease. Another study 27 pointed out that the clinical measures of disease activity and functional disability correlated more with the CRP compared with other laboratory variables. Patients with higher CRP levels may experience more pain and limitation, which may affect their functional capacity and influence their sexuality.
Chronic arthritis including AS has a significant effect on the patients' emotional and physical status. 7, 32 Sexual motivation is an important issue in terms of healthy sexual functioning. Depression is associated with sexual dysfunction and an impaired quality of the sexual activity of the patients. 32, 33 In our study, no significant correlation was observed between the HADS-A and HADS-D levels and the FSFI. Previous studies have pointed out a relationship between depression and sexual dysfunction in patients with AS. 7, 8 It is reported that the Beck Depression Index scores are higher in male patients with AS. Thus, depression has been suggested as a cause of the sexual dysfunction. 9 Nevertheless, these studies were conducted in male patients with AS. In a study focusing on the relationship between female sexuality and depression, Healey et al. 6 have reported that depression in female patients with AS affects the sexual function less than the male patients with AS. In a recent study, 23 the Beck Depression Index scores obtained from the female patients with AS were observed to correlate with the sexual desire, orgasm and the total FSFI scores. Also, in a study they conducted on female patients with RA, Nasser and Ali 5 have observed sexual function to be related to depression, but unrelated to anxiety. In another study conducted also on women, sexual function was found to be associated with depression in patients with fibromyalgia, although the two were found to be unrelated in patients with RA. 34 Very few of the studies focussing on sexuality in AS have investigated the relationship between the sexual function and anxiety. Healey et al. 6 have evaluated male and female AS patients together and reported no association between anxiety and sexual dysfunction. In another study where the general impact of AS on the social life was investigated, the level of anxiety was found to have an impact on sexual function. 35 However, no specifically designed questionnaire was used in this study to evaluate the sexual function. In our study, we did not observe any relationship between anxiety and sexual dysfunction, and this may be related to the exclusion of the AS patients with severe psychological disorders.
In certain previous studies, no relationship was observed between generalised pain values and the disease duration with sexual function. 6, 7, 9 However, there are also studies pointing out that the pain in patients with AS negatively influences the sexual function. 22, 23 One study reported that the resting pain intensity was negatively correlated with the intercourse satisfaction and overall satisfaction in male patients with AS. 22 In the present study, no correlation was found between the disease duration, cigarette smoking, and generalised pain levels, when the total and domain scores in the FSFI were compared. This may be related to the relatively low patient number and the fact that AS has a more moderate course in female patients.
Chronic pain is also known to affect sexual function. 36 The medication used in the treatment of AS may affect the sexual function negatively, although it may also improve sexual function by decreasing the disease activity and pain. In a study where the effect of infliximab on depression, anxiety and the quality of life in patients with AS was assessed, significant improvements in the patients' depression, anxiety and quality of life scores were observed at the end of the 6th week. 37 We did not observe any significant associations between drug treatment and the FSFI scores in our study.
The limitation of this study was its cross-sectional design. Besides, our sample size was rather small. As we did not assess the depression and anxiety scores in the control group, we may have overlooked the possible influence of depression and anxiety on the sexual function in the control group.
CONCLUSION
Sexual function has been found to be lower in female patients with AS. The sexual dysfunction in patients with AS may be associated with the disease activity, functional inadequacy, radiological score, quality of life and the CRP levels as well as the BASFI and BASDAI scores. Sexual dysfunction in female patients with AS occurs due to multifactorial origins. Besides the above-mentioned factors, various other components such as the treatment and the socio-cultural and educational level and past experiences of the patient may have an influence on the sexual function. Thus, sexual dysfunction, which is an element often disregarded in daily practice, must be a focus of consideration in female patients with AS.
